DE69113811D1 - Zusammensetzung zur lokalen anwendung. - Google Patents

Zusammensetzung zur lokalen anwendung.

Info

Publication number
DE69113811D1
DE69113811D1 DE69113811T DE69113811T DE69113811D1 DE 69113811 D1 DE69113811 D1 DE 69113811D1 DE 69113811 T DE69113811 T DE 69113811T DE 69113811 T DE69113811 T DE 69113811T DE 69113811 D1 DE69113811 D1 DE 69113811D1
Authority
DE
Germany
Prior art keywords
composition
local application
liquid phases
application
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69113811T
Other languages
English (en)
Other versions
DE69113811T2 (de
Inventor
Adrian Davis
Jennifer Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE69113811D1 publication Critical patent/DE69113811D1/de
Publication of DE69113811T2 publication Critical patent/DE69113811T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
DE69113811T 1990-11-27 1991-11-21 Zusammensetzung zur lokalen anwendung. Expired - Lifetime DE69113811T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909025711A GB9025711D0 (en) 1990-11-27 1990-11-27 Topical composition
PCT/GB1991/002064 WO1992009266A1 (en) 1990-11-27 1991-11-21 Topical composition

Publications (2)

Publication Number Publication Date
DE69113811D1 true DE69113811D1 (de) 1995-11-16
DE69113811T2 DE69113811T2 (de) 1996-04-11

Family

ID=10686018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113811T Expired - Lifetime DE69113811T2 (de) 1990-11-27 1991-11-21 Zusammensetzung zur lokalen anwendung.

Country Status (19)

Country Link
EP (1) EP0559682B1 (de)
JP (1) JPH06502856A (de)
KR (1) KR100218652B1 (de)
AT (1) ATE128862T1 (de)
AU (1) AU661283B2 (de)
CA (1) CA2096963C (de)
DE (1) DE69113811T2 (de)
DK (1) DK0559682T3 (de)
ES (1) ES2079687T3 (de)
GB (1) GB9025711D0 (de)
GR (1) GR3018613T3 (de)
HK (1) HK1006279A1 (de)
IE (1) IE68953B1 (de)
MY (1) MY108692A (de)
NZ (1) NZ240707A (de)
PT (1) PT99608B (de)
SA (1) SA92120308B1 (de)
WO (1) WO1992009266A1 (de)
ZA (1) ZA919289B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
FR2771634B1 (fr) * 1997-12-02 2000-04-28 Jean Pierre Benoit Produit d'hygiene capillaire et/ou corporelle pour les hommes et les animaux et procede pour sa fabrication
US6649174B2 (en) * 1998-05-07 2003-11-18 E-L Management Corp. Dual phase cosmetic composition
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
DE10235422A1 (de) * 2002-08-02 2004-02-12 Beiersdorf Ag Kosmetische Zubereitungen mit zwei Phasen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) * 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method

Also Published As

Publication number Publication date
GR3018613T3 (en) 1996-04-30
CA2096963A1 (en) 1992-05-28
HK1006279A1 (en) 1999-02-19
MY108692A (en) 1996-10-31
EP0559682A1 (de) 1993-09-15
WO1992009266A1 (en) 1992-06-11
IE68953B1 (en) 1996-07-24
ZA919289B (en) 1992-10-28
CA2096963C (en) 2002-04-30
KR100218652B1 (ko) 1999-09-01
NZ240707A (en) 1994-02-25
PT99608B (pt) 1999-05-31
AU8929591A (en) 1992-06-25
JPH06502856A (ja) 1994-03-31
ATE128862T1 (de) 1995-10-15
ES2079687T3 (es) 1996-01-16
PT99608A (pt) 1992-11-30
IE914090A1 (en) 1992-06-03
KR930702958A (ko) 1993-11-29
SA92120308B1 (ar) 2005-06-15
DK0559682T3 (da) 1995-12-04
DE69113811T2 (de) 1996-04-11
AU661283B2 (en) 1995-07-20
EP0559682B1 (de) 1995-10-11
GB9025711D0 (en) 1991-01-09

Similar Documents

Publication Publication Date Title
MX9305146A (es) Conjugado de interferon, procedimiento para su preracion y composicion farmaceutica que lo contienen.
DE60231417D1 (de) Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind
DE69512685T2 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
BR9403783A (pt) Uso de uma composição cosmética
DE69301356T2 (de) Übersättigte topische zusammensetzungen
DE69113811T2 (de) Zusammensetzung zur lokalen anwendung.
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
EP0391852A3 (de) Arzneimittelzusammensetzungen
FR2804601B1 (fr) Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique
DE69626401D1 (de) Arzneimittel zur topischen anwendung
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
KR900017599A (ko) 종양 치료용 약학 조성물
AR011099A1 (es) Microparticulas y su uso en la preparacion de medicamentos para el tratamiento de cancer.
MC2450A1 (fr) Composition pour le traitement topique d'affections de la peau et des phanères
DE69834434D1 (de) Verbindung und Arzneizusammensetzung zur Verabreichung von Wirkstoffen
EE9700021A (et) Fibriinile mõju avaldav monoklooniline antikeha kasutamiseks tromboosivastases ravis, farmatseutilised kompositsioonid ja ravimaine
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
ES1020814Y (es) Cateter para administracion local de sustancias en alta concentracion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition